Theegarten D, Tötsch M, Worm K, Darwiche K, Anhenn O, Wohlschläger J
Institut für Pathologie and Neuropathologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstrasse 55, Essen, Germany.
Pathologe. 2013 Jul;34(4):305-9. doi: 10.1007/s00292-013-1759-0.
Definitive diagnosis of unclear pulmonary lesions is mainly based on morphological methods. In addition to a neoplasm, inflammatory reactions, in particular tuberculosis (TB), have to be considered in most cases. Therefore, the aim of this work was to determine whether established methods used in general pathology can be efficiently used with cytological material.
An established polymerase chain reaction (PCR) protocol for the detection of Mycobacterium tuberculosis complex (Mtc) DNA in fixed specimens was conducted on fixed material available as an assay for liquid-based cytology (LBC). CytoLyt®-fixed material of 45 patients with clinically suspected TB or other mycobacteriosis were selected and were initially tested cytologically. In cases of absent tumor cells, PCR for detection of Mtc DNA and Ziehl-Neelsen stain (ZN) were performed.
In 9 patients (20 %), Mtc DNA was found by PCR. The following methods were used to obtain material: catheter biopsy (5), needle biopsy (2), transbronchial needle aspiration (1), and bronchoalveolar lavage (1). Cytologically an inflammatory reaction was observed in all cases. In 2 patients, a history of TB, in 2 further cases either silicosis or a posttransplant situation was known. In cases with a positive PCR, 7 patients (78 %) were positive in ZN and 3 patients (33.3 %) in TB culture (15.5 % vs. 6.7 % of the total cohort); however, the material used for investigation was not always from identical sources, respectively. In 36 out of 45 patients, both PCR and ZN were negative for the detection of Mtc DNA.
The material intended for LBC can be used for detection of TB with ZN and Mtc PCR.
不明肺部病变的明确诊断主要基于形态学方法。在大多数情况下,除肿瘤外,还必须考虑炎症反应,尤其是结核病(TB)。因此,本研究的目的是确定常规病理学中使用的既定方法是否能有效地用于细胞学材料。
采用既定的聚合酶链反应(PCR)方案,对作为液基细胞学(LBC)检测可用的固定材料进行结核分枝杆菌复合群(Mtc)DNA检测。选取45例临床疑似结核病或其他分枝杆菌病患者的CytoLyt®固定材料,首先进行细胞学检测。在无肿瘤细胞的情况下,进行检测Mtc DNA的PCR和萋-尼染色(ZN)。
9例(20%)患者通过PCR检测到Mtc DNA。获取材料采用以下方法:导管活检(5例)、针吸活检(2例)、经支气管针吸活检(1例)和支气管肺泡灌洗(1例)。所有病例在细胞学上均观察到炎症反应。2例患者有结核病史,另外2例患者已知患有矽肺或处于移植后状态。在PCR阳性的病例中,7例(78%)ZN染色阳性,3例(33.3%)结核培养阳性(分别占总队列的15.5%和6.7%);然而,用于检测的材料并非总是来自相同的来源。45例患者中有36例,PCR和ZN检测Mtc DNA均为阴性。
用于LBC的材料可用于ZN染色和Mtc PCR检测结核病。